2017
DOI: 10.1016/j.neuropharm.2016.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
47
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 67 publications
(48 citation statements)
references
References 111 publications
(104 reference statements)
1
47
0
Order By: Relevance
“…5). A similar pattern of PC breakdown and enhanced LPA signaling was evidenced in other neurological diseases, such as schizophrenia, and proposed to be involved in demyelination processes (64,65). In the dHC, an increase of PL levels occurs, despite increased cPLA 2 expression, indicating that PL metabolism in the dHC is not solely regulated by cPLA 2 , and that increased cPLA 2 expression is implicated in an alternative pathway.…”
Section: Discussionsupporting
confidence: 58%
“…5). A similar pattern of PC breakdown and enhanced LPA signaling was evidenced in other neurological diseases, such as schizophrenia, and proposed to be involved in demyelination processes (64,65). In the dHC, an increase of PL levels occurs, despite increased cPLA 2 expression, indicating that PL metabolism in the dHC is not solely regulated by cPLA 2 , and that increased cPLA 2 expression is implicated in an alternative pathway.…”
Section: Discussionsupporting
confidence: 58%
“…This bioactive and proinflammatory lysophospholipid is highly produced during inflammation and activates microglial cells which, in turn, self-sustains LPA synthesis4647. Beyond acting on its high-affinity metabotropic receptors LPA1 – 4, LPA also binds to the TRPV1 C-terminal48.…”
Section: Resultsmentioning
confidence: 99%
“…This indicates that LPA 5 signaling is related to neuropathic pain mediated by multiple sclerosis [96]. It was found that intravenous LPA and GGPP (LPA 5 agonists) induced allodynia, but GGPP-induced allodynia did not show up in LPA 5 -KO mice, indicating pain signals in the spinal cord by LPA 5 transfer [94][95][96].…”
Section: Lpar and Neuropathic Painmentioning
confidence: 99%
“…LPA may activate macrophages/microglia via LPAR1 and LPAR3 and promote self-amplification of LPA, increasing microglial migration and pro-inflammatory phenotype through the LPAR5/protein kinase D (PKD) axis. Activation and migration of microglia are associated with demyelination in the spinal cord after injury, and microglia are more involved in the initiation of neuropathic pain (NP) [94,95]. In the cuprizone (CPZ)-induced multiple sclerosis (MS) model, LPA5 signaling mediates pain allergy induced by A-delta fibers and demyelination produced by CPZ.…”
Section: Lpar and Neuropathic Painmentioning
confidence: 99%